Incidence, risk factors and impact on virological response of anemia in chronic genotype 2 hepatitis C receiving sofosbuvir plus ribavirin-Reference-Cited by-同舟云学术

Incidence, risk factors and impact on virological response of anemia in chronic genotype 2 hepatitis C receiving sofosbuvir plus ribavirin

Published:2020-01 Issue:1 Volume:119 Page:532-537
ISSN:0929-6646
Container-title:Journal of the Formosan Medical Association
language:en
Short-container-title:Journal of the Formosan Medical Association

Author:

Chen Chi-Ching,Tung Shui-Yi,Wei Kuo-Liang,Shen Chien-Heng,Chang Te-Sheng,Chen Wei-Ming,Xu Huang-Wei,Yen Chih-Wei,Chen Yi-Hsing,Lu Sheng-Nan,Hung Chao-Hung

Publisher

Elsevier BV

Subject

General Medicine

Reference26 articles.

1. Public health issues of hepatitis C virus infection;Papatheodoridis;Best Pract Res Clin Gastroenterol,2012

2. Hepatitis C. WHO fact sheet 164;World Health Organization,2017

3. Global epidemiology and genotype distribution of the hepatitis C virus infection;Gower;J Hepatol,2014

4. Estimating the incidence and prevalence of chronic hepatitis C infection in Taiwan using back projection;McEwan;Value Health Reg Issues,2014

5. Changing prevalence of hepatitis C virus genotypes: molecular epidemiology and clinical implications in the hepatitis C virus hyperendemic areas and a tertiary referral center in Taiwan;Yu;J Med Virol,2001

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel variant in glycophorin c gene protects against ribavirin-induced anemia during chronic hepatitis C treatment;Biomedicine & Pharmacotherapy;2021-11

2. Sofosbuvir‐based therapies in genotype 2 hepatitis C virus cirrhosis: A real‐life experience with focus on ribavirin dose;Pharmacology Research & Perspectives;2021-06-20